Sensus Healthcare, Inc. (SRTS) News
Filter SRTS News Items
SRTS News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
SRTS News Highlights
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
Latest SRTS News From Around the Web
Below are the latest news stories about SENSUS HEALTHCARE INC that investors may wish to consider to help them evaluate SRTS as an investment opportunity.
Sensus Healthcare, Inc. (SRTS) Stock Slides as Market Rises: Facts to Know Before You TradeThe latest trading day saw Sensus Healthcare, Inc. (SRTS) settling at $6.83, representing a -1.87% change from its previous close. |
Those who invested in Sensus Healthcare (NASDAQ:SRTS) a year ago are up 204%Sensus Healthcare, Inc. ( NASDAQ:SRTS ) shareholders have seen the share price descend 16% over the month. On the other... |
Sensus Healthcare, Inc. (SRTS) Sees a More Significant Dip Than Broader Market: Some Facts to KnowThe latest trading day saw Sensus Healthcare, Inc. (SRTS) settling at $7.21, representing a -1.77% change from its previous close. |
Sensus Healthcare (SRTS) Surges 7.9%: Is This an Indication of Further Gains?Sensus Healthcare (SRTS) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term. |
Sensus Healthcare, Inc.'s (NASDAQ:SRTS) Intrinsic Value Is Potentially 92% Above Its Share PriceKey Insights Using the 2 Stage Free Cash Flow to Equity, Sensus Healthcare fair value estimate is US$15.63 Current... |
Wall Street Bulls Look Optimistic About Sensus Healthcare (SRTS): Should You Buy?The average brokerage recommendation (ABR) for Sensus Healthcare (SRTS) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock? |
Wall Street Analysts Believe Sensus Healthcare (SRTS) Could Rally 36.01%: Here's is How to TradeThe average of price targets set by Wall Street analysts indicates a potential upside of 36% in Sensus Healthcare (SRTS). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock. |
Is Sensus Healthcare (SRTS) Outperforming Other Medical Stocks This Year?Here is how Sensus Healthcare, Inc. (SRTS) and Alnylam Pharmaceuticals (ALNY) have performed compared to their sector so far this year. |
Pompano Veterinary Oncology Partners with Sensus Healthcare to Provide First Superficial Radiotherapy Services in a Mobile ConfigurationFull-service medical oncology practice to pioneer the use of SRT to treat companion animals for both home and veterinary clinic visits BOCA RATON, Fla, Dec. 04, 2024 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological skin conditions, has partnered with Pompano Veterinary Oncology to pioneer the use of SRT to treat companion animals |
Sensus Healthcare (NASDAQ:SRTS) Knows How To Allocate Capital EffectivelyIf you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an... |